<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T11:57:18Z</responseDate>
  <request identifier="oai:figshare.com:article/33920605" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33920605</identifier>
        <datestamp>2026-09-18T05:40:03Z</datestamp>
        <setSpec>category_393</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Changes in gluten-free diet adherence and growth parameters among children with celiac disease during the COVID-19 pandemic.docx</dc:title>
          <dc:creator>Yağmur Erkol Yılmaz (25070260)</dc:creator>
          <dc:creator>Ceyda Tuna Kırsaçlıoğlu (13015709)</dc:creator>
          <dc:creator>Aydan Kansu (13015700)</dc:creator>
          <dc:creator>Arzu Ensari (6485069)</dc:creator>
          <dc:creator>Zarife Kuloğlu (22107630)</dc:creator>
          <dc:subject>Foetal Development and Medicine</dc:subject>
          <dc:subject>celiac disease</dc:subject>
          <dc:subject>COVID-19</dc:subject>
          <dc:subject>gluten-free diet</dc:subject>
          <dc:subject>nutritional status</dc:subject>
          <dc:subject>treatment adherence and compliance</dc:subject>
          <dc:description>Objectives&lt;p&gt;Strict exclusion of gluten is the cornerstone of celiac disease (CD) management; nevertheless, maintaining dietary adherence remains challenging. The COVID-19 pandemic may have influenced dietary adherence in children with CD. This study aimed to investigate the association between the COVID-19 pandemic and gluten-free diet (GFD) adherence and anthropometric measurements.&lt;/p&gt;Methods&lt;p&gt;This retrospective longitudinal cohort study with a cross-sectional survey component included 81 pediatric patients with CD (67.9% female; mean age 14.9 ± 3.4 years) who had been following a GFD for at least one year before the pandemic. Demographic, clinical, laboratory, and anthropometric data from the pre-pandemic, restriction, and post-pandemic periods were obtained from medical records. Dietary adherence was assessed via a structured telephone questionnaire. Participants reporting either complete avoidance of gluten or fewer than six inadvertent gluten exposures annually were categorized as self-reported adherent. Serological adherence was defined by a negative tTG-IgA result.&lt;/p&gt;Results&lt;p&gt;At the beginning of the pandemic in March 2020, the mean duration of GFD was 3.9 ± 2.4 years. At the time of the survey, self-reported adherence was 67.9% (55/81), whereas serological adherence was 77.1% (54/70). During the pandemic, 49.4% of participants reported no change in dietary adherence, 33.3% reported increased adherence, and 17.3% reported decreased adherence. Serological adherence differed significantly across the three longitudinal assessment periods (Cochran's Q = 31.818, p &lt; 0.001). Compared with the pre-pandemic period (51.9%, 42/81), serological adherence was significantly higher during both the restriction period (82.7%, 67/81) and the post-pandemic period (76.5%, 62/81) (McNemar p &lt; 0.001 for both comparisons), whereas no significant difference was observed between the restriction and post-pandemic periods (McNemar p = 0.227). Serological adherence was associated with home-cooking and selected family and socioeconomic factors. Most participants (87.7%) reported difficulty accessing gluten-free products, mainly due to high cost and limited variety. No significant differences were observed in anthropometric measurements across the study periods.&lt;/p&gt;Conclusion&lt;p&gt;Serological adherence was significantly higher during both the COVID-19 restriction and post-pandemic periods than during the pre-pandemic period, while no significant changes in anthropometric measurements were observed.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T05:40:03Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fped.2026.1923034.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Changes_in_gluten-free_diet_adherence_and_growth_parameters_among_children_with_celiac_disease_during_the_COVID-19_pandemic_docx/33920605</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
